Suppr超能文献

2017年加拿大实验室人员接触人类病原体和毒素的监测情况

Surveillance of laboratory exposures to human pathogens and toxins: Canada 2017.

作者信息

Pomerleau-Normandin D, Heisz M, Tanguay F

机构信息

Centre for Biosecurity, Public Health Agency of Canada, Ottawa, ON.

出版信息

Can Commun Dis Rep. 2018 Nov 1;44(11):297-304. doi: 10.14745/ccdr.v44i11a05.

Abstract

BACKGROUND

Under Canada's and , the Public Health Agency of Canada (PHAC) is mandated with monitoring laboratory incident notifications through the Laboratory Incident Notification Canada (LINC) surveillance system. The year 2017 marks the second complete year of data.

OBJECTIVE

To describe the laboratory exposure and laboratory-acquired infection incidents that occurred in Canada in 2017 by sector, human pathogens and toxins involved, number of affected persons, incident type and root causes.

METHODS

The incidents included in the analysis occurred between January 1 and December 31, 2017. They were reported by laboratories with active licences to PHAC through the LINC surveillance system. Microsoft Excel 2010 was used for basic descriptive statistics.

RESULTS

A total of 44 exposure and laboratory-acquired infection incidents were reported to the LINC in 2017. Compared by sector and their respective shares of licences, the number of incidents was highest in the academic and hospital sectors compared with government laboratories and private industry. Altogether 118 people were exposed for an average of 2.7 people per incident (range of 1-29). There were no reports of secondary exposure. Six exposure incidents (14%) led to "suspected" (n=5) or confirmed (n=1) cases of laboratory-acquired infection. Although overall, risk group (RG)2 human pathogens and toxins were involved in the majority of incidents (n=23; 52%), (n=4; 9%) and (n=3; 7%) were the most frequently involved in reported exposure incidents. These two pathogens are both RG3 and security-sensitive biological agents (SSBAs). An average of 2.3 root causes were identified per incident (n=101). Problems with standard operating procedures (SOPs) and human error were the two most common causes.

CONCLUSION

The incidence of laboratory exposure incidents was relatively low in 2017. The most common route of exposure was through inhalation and the most common root causes were problems with SOPs and human error. Since this is a new surveillance system, baseline estimates are still being established.

摘要

背景

根据加拿大的[相关法规],加拿大公共卫生署(PHAC)负责通过加拿大实验室事件通报(LINC)监测系统监测实验室事件通报情况。2017年是有完整数据的第二年。

目的

按部门、所涉及的人类病原体和毒素、受影响人数、事件类型及根本原因,描述2017年在加拿大发生的实验室暴露和实验室获得性感染事件。

方法

纳入分析的事件发生在2017年1月1日至12月31日之间。它们由持有有效许可证的实验室通过LINC监测系统向PHAC报告。使用Microsoft Excel 2010进行基本描述性统计。

结果

2017年LINC共收到44起暴露和实验室获得性感染事件报告。按部门及其各自的许可证份额比较,学术和医院部门的事件数量高于政府实验室和私营企业。共有118人暴露,平均每次事件2.7人(范围为1 - 29人)。无二次暴露报告。6起暴露事件(14%)导致“疑似”(n = 5)或确诊(n = 1)实验室获得性感染病例。虽然总体而言,风险组(RG)2人类病原体和毒素涉及大多数事件(n = 23;52%),但[具体病原体1](n = 4;9%)和[具体病原体2](n = 3;7%)是报告的暴露事件中最常涉及的。这两种病原体均为RG3和安全敏感生物制剂(SSBA)。每次事件平均确定2.3个根本原因(n = 101)。标准操作程序(SOP)问题和人为错误是两个最常见的原因。

结论

2017年实验室暴露事件发生率相对较低。最常见的暴露途径是吸入,最常见的根本原因是SOP问题和人为错误。由于这是一个新的监测系统,仍在确定基线估计值。

相似文献

1
Surveillance of laboratory exposures to human pathogens and toxins: Canada 2017.
Can Commun Dis Rep. 2018 Nov 1;44(11):297-304. doi: 10.14745/ccdr.v44i11a05.
2
Surveillance of laboratory exposures to human pathogens and toxins: Canada 2016.
Can Commun Dis Rep. 2017 Nov 2;43(11):228-235. doi: 10.14745/ccdr.v43i11a04.
3
Surveillance of laboratory exposures to human pathogens and toxins: Canada 2018.
Can Commun Dis Rep. 2019 Sep 5;45(9):244-251. doi: 10.14745/ccdr.v45i09a04.
5
Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2022.
Can Commun Dis Rep. 2023 Sep 1;49(9):398-405. doi: 10.14745/ccdr.v49i09a06.
6
Surveillance of laboratory exposures to human pathogens and toxins, Canada 2020.
Can Commun Dis Rep. 2021 Oct 14;47(10):422-429. doi: 10.14745/ccdr.v47i10a04.
7
Canadian laboratory incidents with human pathogens and toxins: An overview of reports, 2016-2022.
Can Commun Dis Rep. 2024 May 24;50(5):144-152. doi: 10.14745/ccdr.v50i05a04.
8
Multivariate analyses of risk factors associated with laboratory exposure incidents.
Can Commun Dis Rep. 2022 Jul 7;48(7-8):350-355. doi: 10.14745/ccdr.v48i78a06.
10
Laboratory-acquired infections in Canada from 2016 to 2021.
Can Commun Dis Rep. 2022 Jul 7;48(7-8):303-307. doi: 10.14745/ccdr.v48i78a02.

引用本文的文献

1
Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2023.
Can Commun Dis Rep. 2025 Jan 2;51(1):16-25. doi: 10.14745/ccdr.v51i01a03. eCollection 2025 Jan.
2
Canadian laboratory incidents with human pathogens and toxins: An overview of reports, 2016-2022.
Can Commun Dis Rep. 2024 May 24;50(5):144-152. doi: 10.14745/ccdr.v50i05a04.
3
Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2022.
Can Commun Dis Rep. 2023 Sep 1;49(9):398-405. doi: 10.14745/ccdr.v49i09a06.
6
Multivariate analyses of risk factors associated with laboratory exposure incidents.
Can Commun Dis Rep. 2022 Jul 7;48(7-8):350-355. doi: 10.14745/ccdr.v48i78a06.
7
Laboratory-acquired infections in Canada from 2016 to 2021.
Can Commun Dis Rep. 2022 Jul 7;48(7-8):303-307. doi: 10.14745/ccdr.v48i78a02.
8
Zika Virus Infection During Research Vaccine Development: Investigation of the Laboratory-Acquired Infection Nanopore Whole-Genome Sequencing.
Front Cell Infect Microbiol. 2022 Mar 7;12:819829. doi: 10.3389/fcimb.2022.819829. eCollection 2022.
9
Surveillance of laboratory exposures to human pathogens and toxins, Canada 2020.
Can Commun Dis Rep. 2021 Oct 14;47(10):422-429. doi: 10.14745/ccdr.v47i10a04.
10
Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.
Clin Microbiol Rev. 2021 Jun 16;34(3):e0012618. doi: 10.1128/CMR.00126-18. Epub 2021 Jun 9.

本文引用的文献

2
Surveillance of laboratory exposures to human pathogens and toxins: Canada 2016.
Can Commun Dis Rep. 2017 Nov 2;43(11):228-235. doi: 10.14745/ccdr.v43i11a04.
3
The importance of implementing safe sharps practices in the laboratory setting in Europe.
Biochem Med (Zagreb). 2014 Feb 15;24(1):45-56. doi: 10.11613/BM.2014.007. eCollection 2014.
4
Laboratory-associated infections and biosafety.
Clin Microbiol Rev. 1995 Jul;8(3):389-405. doi: 10.1128/CMR.8.3.389.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验